Filing Flows › Comparisons › WVE vs APMD
Wave Life Sciences vs Apnimed: WVE and APMD compared
Wave Life Sciences is the larger company: $13.2M of revenue in its latest quarter (Q3 2026) against $12.1M for Apnimed (Q2 2026). Wave Life Sciences is growing faster (+73% against -29% a year earlier). Apnimed is more profitable, with an operating margin of -96.9% against -502.0%.
Where the money goes: WVE and APMD
Wave Life Sciences (WVE) · Q3 2026
Wave Life Sciences, Q3 2026: revenue $13.2M (+73% year over year), operating margin -502.0%, net loss $61.9M, operating cash flow −$60.1M. The chart follows the revenue to costs, profit and cash.
Apnimed (APMD) · Q2 2026
Apnimed, Q2 2026: revenue $12.1M (-29% year over year), operating margin -96.9%, net earnings $126M. The chart follows the revenue to costs, profit and cash.
| Wave Life Sciences (WVE) | Apnimed (APMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $13.2M | $12.1M |
| Revenue growth, Y/Y | +73% | -29% |
| Operating margin | -502.0% | -96.9% |
| Net earnings | −$61.9M | $126M |
| Net margin | -470.5% | — |
| Operating cash flow | −$60.1M | — |
Questions
Which is bigger, Wave Life Sciences or Apnimed?
Wave Life Sciences is the larger company: $13.2M of revenue in its latest quarter (Q3 2026) against $12.1M for Apnimed (Q2 2026).
Is Wave Life Sciences or Apnimed growing faster?
Wave Life Sciences is growing faster (+73% against -29% a year earlier).
Which is more profitable, Wave Life Sciences or Apnimed?
Apnimed is more profitable, with an operating margin of -96.9% against -502.0%.
More: Wave Life Sciences earnings · how Wave Life Sciences makes money · Apnimed earnings · how Apnimed makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 27, 2026; 10-Q filed Sep 8, 2026). Fiscal quarters can end on different dates. Not investment advice.